Nearly a third of the participants of an observational study on the side-effects of Bharat Biotech's Covid-19 vaccine Covaxin reported adverse events of special interest (AESI), according to a ...
Researchers found that female adolescents and those with a history of allergy are at a higher risk of AESI after receiving Covaxin, according to a report on SpringerLink, an integrated platform ...
Adolescent girls and those with comorbidities are at a higher risk of adverse events after receiving Bharat Biotech’s BBV152 (Covaxin) vaccine against COVID-19, according to a report published ...
Nearly one-third of 926 individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study ...
Covaxin, the Covid-19 vaccine developed by Bharat Biotech, has caused several adverse side effects in recipients, including respiratory tract infections and menstrual abnormalities, a new study ...
An observational study on Bharat Biotech's Covaxin has reported that about one-third of participants experienced adverse events. This follows recent admissions by AstraZeneca regarding side ...
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual ...
Bharat Biotech, the Hyderabad-based manufacturer of Covaxin, has recently responded to a study conducted by Banaras Hindu University (BHU) that raised concerns regarding the vaccine's potential ...
Image Source : PTI/FILE PHOTO A health worker shows the vials for the Covaxin dose at a vaccination centre. A recent study conducted by researchers at Banaras Hindu University (BHU) revealed that ...
New Delhi: Close to one-third of over 900 individuals receiving Covaxin shots have developed some kind of adverse effect whereas upper respiratory tract infections have been found among nearly 50% ...
Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported ‘adverse events of special interest,’ or AESI, according to a one-year follow up study ...